SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph (HBAR) is actively trending as the community debates its future, ignited by news of FedEx joining the Hedera Governing Council and reports of the U.S. Military adopting its quantum-secure technology for drones. While many highlight its real-world utility and undervalued status with strong bullish sentiment, a vocal segment remains bearish, labeling it a 'scam' amidst broader market uncertainty and predicting further dips.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending with high investor anticipation for its pivotal SOL-1 Phase 3 data readout for wet AMD on Tuesday, as a key new commercial leadership hire and ongoing Sanofi acquisition rumors fuel optimism for a significant move and potential short squeeze.

"What's Updog?" is a Community Led token.

UpDog

UPDOG CRYPTO is generating buzz through its community's persistent use of the "Whats UpDog?" meme, actively encouraging others to "Load UpDog" and participate in its Solana-based ecosystem, often celebrating other trending tokens with its namesake.

This is a legacy token commemorating the pseudonym Satoshi Nakamoto.

Satoshi Nakamoto

$SATOSHI is trending as its community highlights its unique position as the decentralized tokenization of the Satoshi Nakamoto name, celebrating it as the ultimate narrative and identity of the entire crypto industry. Holders believe it offers an unparalleled opportunity, representing the "Bitcoin of memes" with limitless cultural and financial upside.

Cooper-Standard Holdings, Inc. engages in the manufacture of sealing and fluid handling systems, including fuel and brake delivery and fluid transfer systems. It operates through the following segments: Sealing Systems, Fluid Handling Systems, and Corporate, Eliminations and Other. The Sealing Systems segment consists of manufacturing products for interior vehicle protection, dust and noise intrusion. The Fluid Handling Systems segment includes products that help convey, connect, control, and communicate throughout the fluid systems. The Corporate, Eliminations and Other segment is for all other business activities. The company was founded in 2004 and is headquartered in Northville, MI.

Cooper-Standard Holdings Inc

Cooper-Standard Holdings is trending due to a fundamentally strong earnings report and positive 2026 outlook, fueled by robust operational performance and significant new business wins in EV and hybrid platforms. The community is actively discussing the company's clear growth trajectory and potential for sustained margin expansion within the evolving automotive sector.

DigitalOcean Holdings, Inc. engages in the provision of providing cloud infrastructure. It operates through the following geographical segments: United States, Netherlands, Germany, Canada, Singapore, and Other. The company was founded in 2012 and is headquartered in Broomfield, CO.

DigitalOcean Holdings Inc

DigitalOcean Holdings is trending following a robust earnings report that significantly surpassed expectations, showcasing accelerating revenue growth, record incremental ARR, and strong expansion into AI/ML workloads with its Gradient AI platform and AMD partnership. The community is actively discussing its position as an undervalued, "slept on" cloud and AI infrastructure play for developers and SMBs, demonstrating impressive relative strength in the software sector.

NextEra Energy, Inc. engages in the provision of renewable energy. It operates through the following segments: FPL and NEER. The FPL segment involves the generation, transmission, distribution, and sale of electric energy in Florida. The NEER segment produces electricity from clean and renewable sources, including wind and solar. The company was founded on December 28, 1925 and is headquartered in Juno Beach, FL.

NextEra Energy Inc

NextEra Energy is trending as its strategic partnerships with tech giants like Google and Meta position it at the forefront of powering AI data centers, a critical driver of surging electricity demand. The community is actively debating its long-term growth potential and perceived undervaluation amidst strong clean energy initiatives, despite recent mixed earnings results.

English version Introducing SWFTCoin (SWFTC) $SWFTC: Powering SWFT Blockchain and AI Services (SWFTGPT)  SwftCoin ($SWFTC) is the native utility token driving SWFT Blockchain's AI-powered ecosystem, SWFTGPT, and the first ever AI token featured on Coinbase. SWFTGPT is also the first domain-specific LLM for crypto.  SwftCoin key features include: 50% Reduced Transaction Fees: Lower costs on all transactions. AI Service Payments: Use $SWFTC to access SWFTGPT. Tools include expert market analysis,  predictions, and intelligent trading solutions.  Membership Benefits: Unlock premium features and AI agent services within SWFTGPT. AI-Powered Swaps: Enable precise, fast cross-chain transactions and analytics. SWFT Blockchain combines AI innovation with blockchain infrastructure, simplifying crypto trading while enhancing functionality through $SWFTC.   Chinese version $SWFTC：驱动 SWFT Blockchain 和 AI 服务（SWFTGPT） SwftCoin ($SWFTC) 是 SWFT Blockchain 的原生实用代币，为其 AI 驱动的生态系统 SWFTGPT 提供支持，同时也是 Coinbase 上首个 AI 代币。SWFTGPT 也是首个专注于加密领域的特定领域大型语言模型 (LLM)。 SwftCoin 的主要功能包括： 1、50% 交易费减免：降低所有交易成本。 2、AI 服务支付：使用 $SWFTC 访问 SWFTGPT 工具，包括专家市场分析、预测以及智能交易解决方案。 3、会员权益：解锁 SWFTGPT 的高级功能和 AI 代理服务。 4、AI 驱动的闪兑：实现精准快速的跨链交易和数据分析。 SWFT Blockchain 将 AI 创新与区块链基础设施结合，通过 $SWFTC 简化加密交易，并提升其功能性。

SwftCoin

SwftCoin ($SWFTC) is trending as the community anticipates a significant price surge, fueled by its recent availability to New York residents on Coinbase and its status as an AI-integrated cross-chain exchange with a fully diluted supply. Many holders are recalling past explosive gains and actively encouraging widespread attention, believing it to be an undervalued utility token poised for another major run amidst discussions of broader crypto market developments and asset tokenization.

Builders FirstSource, Inc. engages in the supply and manufacture of building materials, manufactured components, and construction services to professional homebuilders, sub-contractors, remodelers, and consumers. Its products include factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The company was founded by Kevin P. O'Meara, Donald F. McAleenan and John D. Roach in March 1998 and is headquartered in Irving, TX.

Builders Firstsource Inc

Builders FirstSource is trending amidst intense speculation of a potential acquisition by QXO and recent significant insider buying, which are fueling bullish sentiment. However, the stock is also a focal point of debate due to substantial short interest from major financial institutions, concerns over its debt levels, and mixed outlooks for the housing sector, leaving investors divided.

Dakota Gold Corp. operates as a gold exploration and development company. It is focused on new gold discoveries and opportunities that build on the legacy of the Homestake District. The company was founded in 2017 is headquartered in Lead, SD.

Dakota Gold Corp

Dakota Gold Corp. is gaining attention following recent high-grade drill results and resource expansion at its Richmond Hill and Maitland projects in the historic Homestake District, further bolstered by a strategic capital raise and investment. The community is actively debating the substantial exploration upside and favorable analyst outlook, while acknowledging short-term price volatility despite a strong gold market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Disc Medicine is Now Oversold (IRON)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a...

Disc Medicine (NASDAQ:IRON) Trading Down 40% - What's Next?

Disc Medicine (NASDAQ:IRON) Stock Price Down 40% - Should You Sell...

<ul class="summary-bullets"><li>The agency said that the company must provide evidence of clinical benefit from “adequate and well-controlled trial(s)” for approval.</li><li>Disc Medicine’s bitopertin is one of the 18 drugs to currently have been tapped for fast review by the FDA under its Commissioner's National Priority Voucher program.&nbsp;</li><li>Disc said it would resubmit its application following the completion of its APOLLO trial and expects a fresh decision from the agency by mid-2027.</li></ul>Shares of Disc Medicine (IRON) slumped 21% on Friday after the U.S. Food and Drug Administration refused to approve the company’s bitopertin oral tablets for the treatment of Erythropoietic Protoporphyria.Disc Medicine’s Bitopertin is one of the 18 drugs to currently have been tapped for fast review by the FDA under its Commissioner's National Priority Voucher program announced in June 2025. The program aims to reduce FDA assessment time to one to two months from the standard 10 to 12 months.<h2 class="st-heading-2">FDA’s Rationale</h2>The FDA said in a letter to the company published on Friday that the data submitted by the company is insufficient proof of clinical benefit. The agency said that the company must now provide evidence of clinical benefit from “adequate and well-controlled trial(s)” for approval.The agency also expressed willingness to meet with the company to discuss options including the completion of an ongoing late-stage trial called Apollo and using it to seek a traditional approval.Disc Medicine was seeking approval of the pill in Erythropoietic Protoporphyria, a rare, inherited metabolic disorder causing extreme sensitivity to sunlight and artificial light, leading to immediate, painful skin reactions like burning, redness, and swelling.The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.discmedicine.com/news-releases/news-release-details/disc-medicine-receives-complete-response-letter-fda-bitopertin">confirmed</a> the receipt of the letter and said that it expects to seek a meeting with the agency.“The CRL will delay the potential approval of bitopertin, but we have confidence in the ongoing APOLLO trial…,” CEO John Quisel said. The company also added that the issues raised by the FDA in the letter are “readily addressable” with data from its APOLLO trial expected in the fourth quarter (Q4).The company said it would resubmit its application following the completion of the APOLLO trial and expects a fresh decision from the agency by mid-2027.Last month, Reuters reported that the FDA has delayed the review of bitopertin after its scientists flagged safety and efficacy concerns. The decision was previously slated for January-end but pushed back two weeks.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around IRON stock jumped from ‘bearish’ to ‘bullish’ territory over the past 24 hours, while message volume increased from ‘normal’ to ‘high’ levels.A Stocktwits user now expects the FDA to decide on an approval for the pills only by late 2027. “Debating whether to start a small position now or wait for further downside,” they wrote.<stembedurl>https://www.stocktwits.com/jamonda/message/644968897</stembedurl><a href="https://stocktwits.com/symbol/IRON">IRON stock</a> has gained 5% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/tesla-to-cease-one-time-sale-of-fsd-starting-sunday/cZRdcaLR4t0">Tesla To Cease One-Time Sale Of FSD In Favor Of Subscription Model</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Disc Medicine logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Disc Medicine Stock Slumps After FDA Declines Approval For Inherited Disorder Drug Over Efficacy Concerns

The FDA said in a letter to the company published on Friday that the data submitted by the company is insufficient proof of clinical benefit for bitopertin. 

Equity

The FDA said in a letter to the company published on Friday that the data submitted by the company is insufficient proof of clinical benefit for bitopertin. 


INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc.- IRON INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc...

Disc Medicine, Inc. (NASDAQ:IRON) Given Average Rating of "Moderate Buy" by Brokerages

Disc Medicine, Inc. (NASDAQ:IRON - Get Free Report) has been assigned an average rating of "Moderate Buy" from the thirteen analysts that are currently covering the firm, Marketbeat Ratings reports...

Atle Fund Management AB Purchases 21,038 Shares of Disc Medicine, Inc. $IRON

Atle Fund Management AB increased its position in shares of Disc Medicine, Inc. (NASDAQ:IRON - Free Report) by 85.3% during the 3rd quarter, according to the company in its most recent Form 13F...

Wall Street Analysts Believe Disc Medicine, Inc. (IRON) Could Rally 48.62%: Here's is How to Trade

The consensus price target hints at a 48.6% upside potential for Disc Medicine, Inc. (IRON). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

HC Wainwright Weighs in on Disc Medicine FY2030 Earnings

Disc Medicine, Inc. (NASDAQ:IRON - Free Report) - Investment analysts at HC Wainwright issued their FY2030 earnings per share estimates for Disc Medicine in a research note issued on Monday, January...

Disc Medicine (NASDAQ:IRON) Insider Sells $69,740.00 in Stock

Disc Medicine, Inc. (NASDAQ:IRON - Get Free Report) insider Rahul Khara sold 1,000 shares of Disc Medicine stock in a transaction on Tuesday, January 20th. The stock was sold at an average price of...

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. The company was founded in October 2017 and is headquartered in Watertown, MA.

Disc Medicine Inc

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

Current Price	$55.95
Prev Close	$71.65
Open	$71.63
Dividend Yield	0.00%
50-Day Moving Average	$81.31
Beta	1.08
Avg. Volume	526,677.30
PE Ratio	-13.37

52-Week High	$99.50
52-Week Low	$30.82
Market Capitalization	$2.7B
EPS (Annual)	-$3.96
Price to Book	4.37
Revenue Per Employee	$0.00

IRON
Disc Medicine Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest IRON News

IRONDisc Medicine Inc